June 12th 2025
Most hospitals and health systems are still struggling to find the cybersecurity budget and staffing to succeed.
Medical Crossfire®: Expert Perspectives on Targeting c-Met Overexpression and 𝘔𝘌𝘛 Genomic Alterations in NSCLC – Unveiling the Complexities of 𝘔𝘌𝘛 Dysregulation
View More
Tumor Board: Expert Insights on Managing Classical 𝘌𝘎𝘍𝘙 Mutations, 𝘌𝘎𝘍𝘙 Exon 20 Insertions, and Atypical 𝘌𝘎𝘍𝘙 Mutations in Metastatic NSCLC
View More
Medical Crossfire®: Harnessing the Power of Modern Therapies in Newly Diagnosed Multiple Myeloma
View More
Cases and Conversations™: Sorting Through the Expanding Treatment Options for Patients with Relapsed/Refractory Multiple Myeloma
View More
Evolving Treatment Strategies in Pancreatic Cancer: Current Standards, Emerging Targets, and the Role of Molecular Testing
View More
Cases & Conversations™: Transforming AML Care—Precision Strategies, Evolving Therapies, and Clinical Insights
View More
PER Tumor Board®: Applying Recent Advances to Transform the Treatment Paradigm in SCLC—Expert Perspectives on New Approvals and Emerging Strategies
View More
Medical Crossfire®: Precision Medicine in Glioma Treatment—Integration of Molecular Profiling to Inform Targeted Therapies
View More
Medical Crossfire®: Integrating Next-Generation Endocrine Targeting Therapies to Improve Outcomes for Patients With HR+/HER2- Breast Cancer
View More
GI Tumor Board—Applying Recent Advances in Biomarker Testing and Treatment in Metastatic Colorectal Cancer
View More
Medical Crossfire®: Improving Patient Outcomes in Myeloproliferative Neoplasms With Novel Therapeutic Approaches
View More
Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care
View More
26th Annual International Lung Cancer Congress®
July 25-26, 2025
Register Now!
Community Practice Connections™: Selecting and Sequencing Therapy for Patients with DLBCL in an Era of Expanding Options
View More
8th Annual Live Medical Crossfire®: Hematologic Malignancies
View More
Community Practice Connections™: 14th Asia-Pacific Primary Liver Cancer Expert Meeting
View More
Contextualizing Advances in Relapse Refractory DLBCL: Navigating Biomarkers, Emerging Data, and Adverse Event Management to Transform Patient Care
View More
Burst CME™: Tackling Adverse Events With Targeted Therapies for Diffuse B-Cell Lymphoma
View More
Biomarkers in Diffuse Large B-Cell Lymphoma: Empowering Treatment Decisions to Improve Outcomes
View More
Treating Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Current Options and Emerging Approaches
View More
BURST Expert Illustrations and Commentaries™: Exploring the Mechanistic Rationale for CSF-1R– Directed Treatment in Chronic GVHD
View More
Community Practice Connections™: 23rd Annual International Congress on the Future of Breast Cancer West
View More
(CME) Optimizing Management of Ocular Toxicity in Cancer Patients: The Role of Ophthalmologists in the Spectrum of Care
View More
(COPE) Optimizing Management of Ocular Toxicity in Cancer Patients: The Role of Ophthalmologists in the Spectrum of Care
View More
20th Annual New York Lung Cancers Symposium®
November 15, 2025
Register Now!
PER® Liver Cancer Tumor Board: How Do Evolving Data for Immune-Based Strategies in Resectable and Unresectable HCC Impact Multidisciplinary Patient Management Today… and Tomorrow?
View More
Community Practice Connections™: 6th Annual Precision Medicine Symposium – An Illustrated Tumor Board
View More
Advances In™: Taking R/R B-Cell ALL Management to the Next Level With New CAR T Approval
View More
Navigating Low-Grade Serous Ovarian Cancer – Enhancing Diagnosis, Sequencing Therapy, and Contextualizing Novel Advances
View More
Cases & Conversations™: Integrating Novel Approaches to Treatment in First-line ALK+ mNSCLC – Enhancing Patient Outcomes with Real World Multidisciplinary Strategies
View More
George Van Antwerp on Understanding the Right Data to Address Health Disparities
November 4th 2021Using and analyzing data for some subpopulations is still in the early stages and there remain a lot of questions around what is the right data to collect, said George Van Antwerp, MBA, managing director, Deloitte Consulting.
Dr. Edmondo Robinson Outlines Hospital Readiness to Receive Large Amounts of Patient Data
October 15th 2021Hospitals and health systems are largely not equipped to handle all the patient data they could receive and turn it into actionable information, explained Edmondo Robinson, MD, MBA, MS, FACP, senior vice president and chief digital officer at Moffitt Cancer Center.
AI Success in Healthcare Requires Transparency, Public-Private Partnership
August 10th 2021In order for artificial intelligence (AI) in healthcare to be successful, there needs to be more transparency around the data that goes into an algorithm, explained John Halamka, M.D., president of Mayo Clinic Platform.
Podcast: Addressing the Dangers of Drug Diversion in Healthcare Settings with Tom Knight
August 3rd 2021Tom Knight, founder and CEO of Invistics, discusses how the COVID-19 pandemic has highlighted the need for better solutions for drug diversion, where healthcare employees commit medication theft, within their healthcare organizations and how technology can help resolve the issue.
Podcast: How Remote Patient Monitoring Can Improve Chronic Disease Management
July 13th 2021Tanvi Abbhi and Nora Zetsche, MD, cofounders of Veta Health, discuss the company’s remote patient monitoring (RPM) platform and how RPM can be used to personalize and improve healthcare for patients with chronic diseases.
Podcast: A Healthcare Administrators’ Guide to AI and Predictive Analytics with Carol McCall
May 18th 2021Carol McCall, from ClosedLoop.ai., discusses what’s holding back healthcare administrators from taking advantage of what artificial intelligence (AI) platforms have to offer and what the future holds for AI and machine learning in healthcare.
Survey of Hospital Revenue Cycle Leaders Sees a Future of More Automation, Remote Work
April 12th 2021Besides the ability to ramp up quicky, healthcare leaders are looking for systems that can accommodate remote work—and some predict that certain workers who fled offices due to COVID-19 will never return to traditional settings.